These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Is hemodiafiltration the dialysis modality of choice for the next decade? Canaud B; Kerr P; Argilés A; Flavier JL; Stec F; Mion C Kidney Int Suppl; 1993 Jun; 41():S296-9. PubMed ID: 8320941 [No Abstract] [Full Text] [Related]
7. Sodium and dialysis: a deeper insight. Locatelli F; Ponti R; Pedrini L; Di Filippo S Int J Artif Organs; 1989 Feb; 12(2):71-4. PubMed ID: 2707908 [No Abstract] [Full Text] [Related]
8. Treatment of severe hypercalcemia using continuous renal replacement therapy with regional citrate anticoagulation. Kindgen-Milles D; Kram R; Kleinekofort W; Morgera S ASAIO J; 2008; 54(4):442-4. PubMed ID: 18645366 [TBL] [Abstract][Full Text] [Related]
9. Adding citrates to bicarbonate concentrates in the preparation of citrate-enriched hemodialyzates. Ing TS; Cheng YL; Yu AW; Kjellstrand CM Hemodial Int; 2011 Jul; 15(3):427-8. PubMed ID: 21624041 [No Abstract] [Full Text] [Related]
10. Regional citrate anticoagulation in continuous venovenous haemofiltration using commercial preparations. Munjal S; Ejaz AA Nephrology (Carlton); 2006 Oct; 11(5):405-9. PubMed ID: 17014553 [TBL] [Abstract][Full Text] [Related]
11. Clinical quiz: Mysterious hyperkalemia and cardiac arrest in a newborn infant undergoing continuous veno-venous hemofiltration dialysis: acute hyperkalemia. Bar-Joseph G; Tarabia M; Halberthal M; Khatib I; Eisenstein I; Zelikovic I Pediatr Nephrol; 2008 Jul; 23(7):1053-7. PubMed ID: 18431603 [No Abstract] [Full Text] [Related]
12. Delay in onset of metabolic alkalosis during regional citrate anti-coagulation in continuous renal replacement therapy with calcium-free replacement solution. See KC; Lee M; Mukhopadhyay A Ann Card Anaesth; 2009; 12(2):122-6. PubMed ID: 19602736 [TBL] [Abstract][Full Text] [Related]
13. Continuous venovenous haemofiltration with citrate-buffered replacement solution is safe and efficacious in patients with a bleeding tendency: a prospective observational study. Nurmohamed SA; Jallah BP; Vervloet MG; Yldirim G; ter Wee PM; Groeneveld AB BMC Nephrol; 2013 Apr; 14():89. PubMed ID: 23597045 [TBL] [Abstract][Full Text] [Related]
14. Regional citrate anticoagulation for single-needle hemodialysis: a prospective clinical study. Gubensek J; Buturovic-Ponikvar J; Ponikvar R Blood Purif; 2007; 25(5-6):454-6. PubMed ID: 18057876 [TBL] [Abstract][Full Text] [Related]
15. Calcium-free hemodialysis for hypercalcemia of malignancy in a newborn. Pradhan M; Leonard MB Pediatr Nephrol; 2003 May; 18(5):474-6. PubMed ID: 12687453 [TBL] [Abstract][Full Text] [Related]
17. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Morgera S; Schneider M; Slowinski T; Vargas-Hein O; Zuckermann-Becker H; Peters H; Kindgen-Milles D; Neumayer HH Crit Care Med; 2009 Jun; 37(6):2018-24. PubMed ID: 19384210 [TBL] [Abstract][Full Text] [Related]
18. Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration. Hetzel GR; Taskaya G; Sucker C; Hennersdorf M; Grabensee B; Schmitz M Am J Kidney Dis; 2006 Nov; 48(5):806-11. PubMed ID: 17060000 [TBL] [Abstract][Full Text] [Related]
19. High-volume continuous venovenous hemofiltration as an effective therapy for acute management of inborn errors of metabolism in young children. Lai YC; Huang HP; Tsai IJ; Tsau YK Blood Purif; 2007; 25(4):303-8. PubMed ID: 17643056 [TBL] [Abstract][Full Text] [Related]
20. Modeled dalbavancin transmembrane clearance during intermittent and continuous renal replacement therapies. Vilay AM; Shah KH; Churchwell MD; Patel JH; DePestel DD; Mueller BA Blood Purif; 2010; 30(1):37-43. PubMed ID: 20588011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]